Quotes 5-day view Delayed Japan Exchange
06/30/2022
07/01/2022
07/04/2022
07/05/2022
07/06/2022
Date
3470(c)
3476(c)
3529(c)
3571(c)
3624(c)
Last
3 418 100
2 828 500
1 620 600
1 399 000
2 598 000
Volume
-1.64%
+0.17%
+1.52%
+1.19%
+1.48%
Change
Estimated financial data (e) JPY USD
Sales 2022
1 186 B
8 732 M
8 732 M
Net income 2022
341 B
2 511 M
2 511 M
Net cash position 2022
516 B
3 801 M
3 801 M
P/E ratio 2022
17,5x
Yield 2022
2,15%
Sales 2023
1 034 B
7 612 M
7 612 M
Net income 2023
313 B
2 304 M
2 304 M
Net cash position 2023
759 B
5 591 M
5 591 M
P/E ratio 2023
19,0x
Yield 2023
2,28%
Capitalization
5 960 B
43 889 M
43 889 M
EV / Sales 2022
4,59x
EV / Sales 2023
5,03x
Nbr of Employees
7 664
Free-Float
37,8%
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Ratings of Chugai Pharmaceutical Co., Ltd
All news about CHUGAI PHARMACEUTICAL CO., LTD
News in other languages on CHUGAI PHARMACEUTICAL CO., LTD
Analyst Recommendations on CHUGAI PHARMACEUTICAL CO., LTD
TIMELINE-Toshiba's lurch from crisis to crisis since 2015
Chart CHUGAI PHARMACEUTICAL CO., LTD
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
3 624,00 JPY
Average target price
4 577,69 JPY
Spread / Average Target
26,3%
Please enable JavaScript in your browser's settings to use dynamic charts.